# Safety and Efficacy Study of DCVax-Direct in Solid Tumors

> **NCT01882946** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Northwest Biotherapeutics** · enrollment: 60 (estimated)

## Conditions studied

- Locally Advanced Tumor
- Metastatic Solid Tissue Tumors
- Liver Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Melanoma

## Interventions

- **BIOLOGICAL:** DCVax-Direct

## Key facts

- **NCT ID:** NCT01882946
- **Lead sponsor:** Northwest Biotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01882946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01882946, "Safety and Efficacy Study of DCVax-Direct in Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01882946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*